Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000891618-96-001074
Filing Date
1996-06-28
Accepted
1996-06-28 00:00:00
Documents
12
Period of Report
1996-03-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR PERIOD ENDING 3-31-96 10-K 252958
2 AMENDMENT TO PREFERRED SHARES RIGHTS AGREEMENT EX-4.2 3393
3 DECLARATION OF REGISTRATION RIGHTS EX-4.3 22773
4 AMEND. TO EXHANGE PROFIT/LOSS SHARE AGREEMENT EX-10.55 2178
5 DEFERRED COMPENSATION PLAN EX-10.56 29788
6 EMPLOYMENT AGREE.-TARGET & RAY H. DORMANDY JR. EX-10.57 11221
7 LETTER AGREE. - TARGET & JOHN C. MEYER EX-10.58 4471
8 LETTER AGREE. - TARGET & ABHI ACHARYA, PH.D EX-10.59 5181
9 CALCULATION OF NET INCOME PER SHARE EX-11.1 2556
10 SUBSIDIARIES OF TARGET THERAPEUTICS, INC. EX-21.1 2369
11 FINANCIAL DATA SCHEDULE EX-27 2195
12 FINANCIAL STMTS & SCHEDULE OF TARGET-CMI EX-99.1 32832
  Complete submission text file 0000891618-96-001074.txt   374648
Mailing Address 47201 LAKEVIEW BLVD FREMONT CA 94538
Business Address 47201 LAKEWIEW BLVD FREMONT CA 94538 5104407700
TARGET THERAPEUTICS INC (Filer) CIK: 0000882238 (see all company filings)

EIN.: 953962471 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-19801 | Film No.: 96588224
SIC: 3841 Surgical & Medical Instruments & Apparatus